Next Article in Journal
Improved Flotation of Fine Flake Graphite Using a Modified Thickening Process
Next Article in Special Issue
Comparative Study of Conventional, Microwave-Assisted and Supercritical Fluid Extraction of Bioactive Compounds from Microalgae: The Case of Scenedesmus obliquus
Previous Article in Journal
Hollow-Fiber Liquid-Phase Microextraction (HF-LPME) Coupled On-Line to Liquid Chromatography for the Determination of the Herbicides 2,4-Dichlorophenoxyacetic Acid and 2-Methyl-4-chlorophenoxyacetic Acid and Their Main Metabolites in Soil Samples
Previous Article in Special Issue
Antioxidant-Activity-Guided Purification and Separation of Octocrylene from Saussurea heteromalla
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Separations
Volume 10
Issue 5
10.3390/separations10050274
separations-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cucumis metuliferus L. Fruits Extract with Antioxidant, Anti-Inflammatory, and Antidiabetic Properties as Source of Ursolic Acid

by
Anna Cazanevscaia Busuioc
1,
Giorgiana Valentina Costea
2,
Andreea Veronica Dediu Botezatu
1,
Bianca Furdui
1,* and
Rodica Mihaela Dinica
1,*
1
Department of Chemistry, Physics and Environment, “Dunărea de Jos” University of Galati, 111 Domnească Street, 800201 Galati, Romania
2
Department of Food Science, Food Engineering and Applied Biotechnology, “Dunărea de Jos” University of Galati, 111 Domnească Street, 800201 Galati, Romania
*
Authors to whom correspondence should be addressed.
Separations 2023, 10(5), 274; https://doi.org/10.3390/separations10050274
Submission received: 31 March 2023 / Revised: 20 April 2023 / Accepted: 21 April 2023 / Published: 23 April 2023
(This article belongs to the Special Issue Separation, Extraction and Purification of Natural Products)
Browse Figures
Versions Notes

Abstract

:
To identify healthy, nutritious, and sustainable plant-based products rich in biologically active compounds, this present study was conducted, and the phytochemical composition and biological properties of the hydroethanolic ultrasound-assisted extract of the fruits of Cucumis metuliferus were investigated. Cucumis metuliferus is an unexplored fruit of a climbing plant in the Cucurbitaceae family, widely distributed in the tropical and subtropical regions of sub-Saharan Africa and whose nutritional and medicinal benefits are well known in African countries, especially. Therefore, its cultivation in other regions could influence chemical composition. The structural identification of the compounds from the hydroethanolic extract from Cucumis metuliferus fruits grown in Romania was carried out by chromatographic techniques (HPLC). The main compounds identified were catechin, oleanolic acid, ursolic acid, p-coumaric acid, and epicatechin. Subsequently, a method was proposed to isolate and characterize ursolic acid, one of the major compounds. The obtained results show that the hydroethanolic extract is rich in antioxidant compounds evaluated using the DPPH radical inhibition method (IC50 = 32.74 ± 0.02 µg/mL) and ABTS cation radical inhibition method (IC50 = 11.37 ± 0.07 µg/mL). It also demonstrate in vitro anti-inflammatory activities, such as anti-lipoxygenase (IC50 = 32.90 ± 0.05 µg/mL) and anti-proteinase (IC50 = 16.34 ± 0.07 µg/mL), and antidiabetic properties by inhibiting α-amylase (IC50 = 429.541 ± 0.25 µg/mL) and β-glucosidase activity (IC50 = 385.685 ± 0.76 µg/mL). Therefore, C. metuliferus fruits could be effectively used in the development of various health-promoting products, being not only appetizing, with spectacular appearance and with extended storage life, but also curative and healthy.

Graphical Abstract

1. Introduction

In recent years, healthy food and the high prevalence of malnutrition have become a topic of interest as diet affects human health and the sustainability of the planet [1,2]. Increasingly, people around the world are recognizing the importance of promoting healthy and sustainable food systems in order to ensure food security for the current global population as well as for generations to come [3,4]. Today’s society’s high interest in swapping some foods for healthier versions and also improving the nutritional profile has led to major changes in the food industry [5,6]. In this context, due to a rich composition in a variety of essential nutrients, vitamins, minerals, antioxidant compounds, and good adaptation to climate changes, Cucumis metuliferus can be an important ingredient for improving different food products for healthy diets with high nutritional potential, essential for human health and sustainable food for the future. This aspect is especially important for people with special dietary restrictions due to certain medical conditions [7,8,9,10,11]. Different parts of this plant (the fruit’s pulp and seeds) can be used for their nutritional and medicinal properties [12,13], rapid growth, and long shelf life (over 6–7 months without cold storage) [14], alongside other nutritious vegetables and fruits, to achieve the most benefit from a healthy diet.
Cucumis metuliferus is a species of the cucurbit (Cucurbitaceae) family with ellipsoid fruits of green color that change to orange color during ripening [15]. The rind is covered with cone-shaped protuberances with pointed tips. Inside, the fruit contains a juicy, green, slimy mass with many white seeds [16]. The fruits come in two forms, the bitter form containing mainly cucurbitacins (triterpenoids), and the non-bitter form, which is more cultivated [17]. This plant is native to Africa and has been mentioned in other studies as jelly melon, horned cucumber, spiked melon, horned melon, or kiwano. It is internationally spread due to its rapid growth and adaptation to various climate conditions. Its history began approximately in 1982 with a family from New Zealand who started to cultivate it for commercial purposes. In just two years, they managed to export the “phenomenal” fruit to Japan, where it was received with curiosity and interest. Later, it became a fruit of interest among American farmers and then easily entered other markets. Under the name of horned melon, this plant soon reached Europe [12,18]. Currently, this plant is cultivated in many countries, and opinions about its taste and appearance are divided.
It is well known that the chemical compounds of each species may vary due to various factors such as variety, maturity, growing conditions, and soil [16]. Moreover, the variation in the chemical composition can lead to differences in therapeutic properties [19]. Therefore, different parts of medicinal plants can potentially be excellent sources of phytochemical compounds with biological activity. In general, fruits contain a combination of important nutrients, such as proteins, carbohydrates, fats, vitamins, and minerals. The seeds are rich in linoleic and oleic acids, which are important for human health. In particular, some studies show that oleic acid can help lower blood pressure [17,20,21]. γ-tocopherol and α-tocopherol identified in considerable quantities in kiwano fruits are two types of vitamin E known for their antioxidant capacity [22]. The fruit of C. metuliferus has a wide list of health benefits due to its varied phytochemical composition. The pulp contains considerable amounts of β-carotene, vitamin A, and vitamin C, which are very important for strengthening the immune system, night vision, or the curative effect of the skin [23,24]. In addition, a wide range of other secondary metabolites has been identified, such as glycosides, alkaloids, flavonoids, saponins, steroids, tannins, and terpenoids [25]. The fruits are also characterized by a high content of minerals such as iron, potassium, phosphorus, zinc, magnesium, copper, calcium, and sodium [15]. Among the numerous secondary metabolites contained by C. metuliferus species, ursolic acid (UA) (3β-3-hydroxy-urs-12-en-28-oic-acid) is a compound of great interest. This pentacyclic triterpenoid compound has low toxicity and is known for its beneficial therapeutic properties, including antioxidant, antimicrobial, hepatoprotective, immunomodulatory, antiviral, antitumor, chemopreventive, anti-inflammatory, cardioprotective, antihyperlipidemic, and hypoglycemic properties [26,27]. Thus, some studies have shown that it can help prevent and treat obesity by modulating fat and glucose metabolism and reducing fat storage in cells [28]. In addition, ursolic acid can help to relieve diabetes symptoms by lowering blood sugar levels and stimulating insulin secretion. In the case of the inflammatory process, UA can help to reduce it by modulating the activity of inflammatory enzymes and blocking molecules that trigger inflammation [26,27,29]. Various technologies are known for UA extraction and purification, both traditional (maceration, Soxhlet, heat reflux) and modern (microwaves, ultrasound, and supercritical fluid) [27,30]. In recent years, researchers have explored structural modifications of ursolic acid intending to produce novel derivatives that possess enhanced biological activities and increased bioavailability [31,32,33,34].
For the purification of various compounds from extracts of various plants, different methods and different auxiliary substances were used [35,36]. Other methods for the purification of UA are based on chromatographic separation of crude extracts, on the column with macroporous adsorbent resins or silica gel [37], by thin-layer chromatography [38], or by fractioned extraction with solvents. Ursolic acid is almost non-toxic and is used in various cosmetics and health products either as an active ingredient or in a mixture with other active substances. In addition, it can be used as a natural compound in the semi-synthesis of numerous new bioactive molecules [39].
Our study aimed to assess the phytochemical profile and the antioxidant, anti-inflammatory, and antidiabetic activities of ultrasound-assisted extracts from C. metuliferus “Tempus” fruits grown in Romania (Southeastern Europe). Furthermore, the study proposes a new method for the separation and purification of one of the major compounds, ursolic acid, from C. metuliferus “Tempus” fruit extracts, which will be further explored in future studies as a lead compound for the development of new derivatives with therapeutic properties.

2. Materials and Methods

2.1. Reagents, Plant Materials, and Apparatus

All reagents and solvents used for isolation, purification, and analysis were purchased from Sigma-Aldrich and Merck (Darmstadt, Germany). The ethanol used for extraction was of analytical grade. The standard compound ursolic acid (≥95%, HPLC grade) was also purchased from Merck. All optical density measurements for antioxidant, anti-inflammatory, and antidiabetic activities were performed with a multiplate reader (Tecan Trading AG, Tecan Pro 200, Männedorf, Switzerland). The fruits used in this study were collected at the ripening stage from the Station of Vegetable Research and Development (SCDL), Buzau, Muntenia Region, Romania (Southeastern Europe, 45°09′30.1′′ N 26°49′39.2″ E). An ultrasonic bath was used for the extraction with solvents (Bandelin Sonorex Ultrasonic, Berlin, Germany, with a digital timer, temperature control, and a frequency of 35 kHz).

2.2. Preparation of Crude Exact of C. metuliferus

Fruits of C. metuliferus “Tempus” were examined for integrity, absence of dust, and insect contamination, then cleaned in the first stage with ultrapure water as a first step. Then, the fresh fruits were washed with deionized water, cut into small pieces, and dried at 50 °C in a hot air oven for 48 h. The dried fruits were ground in an electronic mill, and the resulting powder was passed through a 60-mesh sieve. The obtained powdered and dried material was stored in a dark and dry place until use.
The dry material was successively extracted three times, with hexane, under reflux, filtered, and dried, followed by a repetitive extraction with 70% ethanol in an ultrasonic bath. The optimal time and temperature conditions for ultrasonic extraction were selected from the literature [40]: 40 ± 5 °C and 60 min. The final step consisted of the evaporation of the solvent with a rotary evaporator. The obtained extract was kept at 2–4 °C and further used in the following analyses and for the isolation and purification of the ursolic acid [41,42].

2.3. HPLC-DAD Analysis of the Extract

High-performance liquid chromatography studies using photodiode arrays (HPLC-DAD) were performed with equipment (Rigol Technologies Inc., Beijing, China), with an autosampler, binary pump, vacuum degasser, and photodiode array detector. A Synergi Polar-RP C18 (250 × 4.6 mm, 4 µm) analytical column (Phenomenex, Chesire, UK), preceded by a security cartridge, was used for chromatographic separation. Quantification of the different analytes was performed according to the validated method as described in other studies [43]. Quantification curves were generated by injecting 1 to 50 mg/L of the standard compound solutions at five different concentrations. Thus, correlation coefficients (R2) greater than 0.99 were obtained, indicating a good linearity of the HPLC-DAD method. The mobile phase was a mixture of 0.1% formic acid in water (v/v) and 0.1% formic acid in methanol (v/v) [13]. UV-visible spectra (210–520 nm) for the analyzed compounds were recorded so that each compound was analyzed at the corresponding wavelength; the data are presented in Table 1. The organic compounds were identified by combining the following data: comparison with standard compounds, retention time, and elution order, and quantified by using quantification curves of the analyzed compounds.

2.4. Isolation and Purification of Ursolic Acid from C. metuliferus Extract

The isolation and purification of ursolic acid were carried out from the hydroethanolic extract of C. metuliferus species, obtained as previously described, using silica gel column chromatography, then analyzed by HPLC-DAD. The ethanolic extract was subjected to column chromatography using a silica gel column (30 × 2.0 cm) preconditioned with chloroform. For elution, a solution of 2 to 4% methanol in chloroform was used. The eluent was collected at every 3–5 mL fraction. After, all the fractions that were collected during the elution process were subjected to TLC testing on silica gel 60 F254 plates (Merck, Darmstadt, Germany). A mixture of chloroform: methanol (95:5, v/v) was used as the mobile phase, and UV light was used for revealing (254 nm, 365 nm, and white light). The fractions with the same Rf were combined and subjected to solvent evaporation [41,44].

2.5. Structure Elucidation and Identification of the Isolated Compound

2.5.1. Attenuated Total Reflection Fourier Transform Infrared Spectroscopy (FTIR-ATR) Analysis

The obtained fractions were analyzed using a Nicolet iS50 FT-IR spectrometer (Thermo Scientific, Waltham, MA, USA) assembled with an ATR accessory. The analysis was performed with a resolution of 4 cm−1 by coaddition of 32 scans in the range 4000 cm−1–400 cm−1. Air was carried out as a reference for the background spectrum before each sample analysis, and the diamond crystal was cleaned with alcohol after each sample. Analyses were performed in a temperature-controlled room (21 ± 2 °C) [45].

2.5.2. Analysis of Fraction by UHPLC-MS

In order to certify the presence of ursolic acid in the obtained fraction, the analysis using ultrahigh-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS) was performed. A method similar in certain parameters was used, with a mobile phase similar to that previously described, while maintaining the parameters for MS. For ionization, a HESI (Heated ElectroSpray Ionization) ion source in negative mode was used. The calibration solution was used for external calibration in both negative and positive modes. Full scan HRMS (high-resolution mass spectrometry) analysis of the compounds was accomplished using a mass spectrometer from Q-Exactive. Full scan data in negative mode were recorded at 70,000 FWHM resolving power, at m/z 200. A scan range of m/z 100–1000 Da was chosen. The temperature of the heat source and capillary was set at 300 °C [46,47].

2.5.3. NMR Analysis

Samples for NMR (nuclear magnetic resonance) experiments were performed in deuterated solvent, CD3OD, and analyzed using a Varian mercury-plus spectrometer, 400 MHz for 1H. 1H chemical shifts were reported in parts per million (ppm), while the coupling constant (J) was Hertz (Hz) (Figures S1–S3, Supplementary Materials) [48].

2.6. Antioxidant Assay

2.6.1. DPPH Scavenging Activity

The antioxidant activity of the extract was analyzed by the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging test [49]. This method is based on the change of purple color to yellow, resulting in a reduced structure of the DPPH radical. The method was performed in a 96-well plate, and the absorbance was recorded at 517 nm after 30 min using a microplate reader. Calculations were made according to the literature [46,50]. The standard compound Trolox was used as a positive control due to its known antioxidant properties [51].

2.6.2. ABTS Radical Cation Decolorization Assay

For this antioxidant activity, a previously prepared solution of ABTS•+ (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) was used [52,53]. The assay was performed according to the descriptions in the literature, with minor modifications [54,55]. The absorbance of the solution was measured at 734 nm in a 96-well plate using the microplate reader. Samples were prepared by mixing 100 μL of the kiwano extract with 100 μL of ABTS•+ radical cation solution, and after 30 min, the absorbance was measured. Results were conveyed using a Trolox calibration curve.

2.7. In Vitro Anti-Inflammatory Activities

2.7.1. Anti-Lipoxygenase Activity

To perform the test, a reaction mixture (200 µL) was obtained by adding 160 µL of sodium phosphate buffer (pH 8.0) to 10 µL of the sample dissolved in Tris buffer (pH 7.4) at various concentrations, and also 20 µL of lipoxygenase. The reaction mixture was incubated at 25 °C for 10 min. To initiate the reaction, 10 µL of the linoleic acid solution was added as substrate and incubated at 25 °C for 6 min, and the absorbance at 234 nm was read in the microplate reader [46,56,57]. Indomethacin (250–255 µg/mL) was used as a positive control due to its known anti-lipoxygenase properties. The percentage of inhibition was calculated using the following formula:
% Inhibition = (AControl − ASample)/(AControl) × 100

2.7.2. Anti-Proteinase Action

In this method, samples dissolved in 20 mM Tris-HCl buffer (pH 7.4)) were mixed with trypsin solution. The reaction mixture was incubated for 5 min at 37 °C and then 0.3 mL of 1.5% casein (w/v) was added. Then, the obtained mixture was again incubated for 20 min. The final step to complete the reaction was performed by adding 200 µL of 70% perchloric acid. Prior to spectrophotometric analysis of the samples, consisting of absorbance measurement at 210 nm, the mixture was centrifuged for 5 min at 5000 rpm [58,59]. Aspirin (10–500 µg/mL), a known inhibitor of proteinase activity, was used as a positive control. The percentage of inhibition was calculated according to the following equation:
% Inhibition = (AControl − ASample)/(AControl) × 100

2.8. In Vitro Evaluation of the Antidiabetic Activity

The α-amylase inhibition test was assessed with the 3,5-dinitrosalicylic acid (DNS) method [60], with minor modifications. Briefly, 80 µL of each sample or positive control was added to 40 μL of α-amylase solution (2 U/mL, α-Amylase from Aspergillus oryzae, EC Number: 232-588-1, Sigma-Aldrich®) and incubated for 20 min at 37 °C. After incubation, 140 μL of 1% starch solution was added to each tube and incubated again for 30 min. The reaction was terminated by adding 0.40 mL of DNS 1% and heating it in a boiling water bath for 10 min. The reaction mixture was cooled to room temperature and then diluted with 0.80 mL phosphate buffer when the absorbance at 540 nm was measured. The blank sample was prepared by replacing the plant extract samples with 0.20 mL of phosphate buffer. A positive control sample was prepared using acarbose (0.025–1 mg/mL), a known amylase inhibitor [61]. The α-amylase inhibitory activity was expressed as a percentage of inhibition and calculated according to the following formula:
% α-amylase Inhibition = (AControl − ASample)/(AControl) × 100
The β-glucosidase inhibition test was assessed as previously described [62]. Briefly, a reaction mixture was obtained from 15 μL phosphate buffer (pH 5.0), 20 μL p-nitrophenyl-β-D-glucopyranoside (1mg/mL, Sigma-Aldrich®) and 20 μL sample or positive control at different concentrations. The 96-well plates were incubated in a microplate reader for 10 min at 37 °C. Then, 5 μL β-glucosidase (from almonds, Sigma-Aldrich®) solution was added (2.5 mg/mL) to each well and incubated again for 30 min at 37 °C. The reaction was terminated by addition of 0.140 mL buffer (pH = 10). Absorbance was measured at 410 nm using a microplate reader. As positive control, acarbose was used, being a known inhibitor of glucosidase [62]. The β-glucosidase inhibitory activity was expressed as a percentage of inhibition and calculated according to the Formula (4).
% β-glucosidase Inhibition = (AControl − ASample)/(AControl) × 100

2.9. Statistical Analysis

The carried experiments were achieved in triplicate, and the presented data represent the average of the three individual determinations ± standard deviation (SD). Statistical evaluation of the obtained data was estimated by one-way analysis of variance (ANOVA) to find out significant differences (p ≤ 0.05). The inhibitory concentration IC50 values were calculated from linear regression analysis of the percent activity depending on concentration by using the GraphPad Prism software (vs. 5.0).

3. Results and Discussion

3.1. Preparation of Crude Exact of C. metuliferus

The current study presented an adapted method for obtaining a hydroethanolic ultrasound-assisted extract of C. metuliferus. Further, for the purification and characterization of ursolic acid, one of the major terpenoid compounds, two steps were proposed, using two solvents with different polarities. The first step was to remove the other compounds. The combined filtrate obtained after extraction was concentrated under reduced pressure to obtain, from 1 kg of plant material, 183 g of crude extract, which has been used for the following analyses and also for the isolation and purification of the major terpenoid compound, ursolic acid. Figure 1 shows the scheme for obtaining the crude extract starting from the fresh fruits of C. metuliferus.

3.2. Identification of Bioactive Compounds by HPLC

The results of this study concerning the chemical composition of the hydro-ethanolic extract from the fruit of C. metuliferus, obtained by HPLC-DAD analysis, are presented in Table 1. Thus, for the compound class of flavan-3-ols, the highest amount of catechin (6576.76 ± 3.89 μg/g dry extract) and epicatechin (2016.71 ± 3.59 μg/g dry extract) and the lowest amount of procyanidin B2 (35.88 μg/g dry extract) were determined.
In the case of hydroxycinnamic acids compounds, p-coumaric acid (116.11 ± 1.46 μg/g dry extract) was identified in the highest concentration, followed by chlorogenic acid (77.39 ± 0.15 μg/g dry extract). Several representative flavonoids, such as rutin (39.42 ± 0.23 μg/g dry extract) and kaempferol-3-glucoside (21.90 ± 0.70 μg/g dry extract), were identified in much smaller amounts compared to other compounds. Additionally, the pentacyclic triterpenoids, ursolic acid (577.31 ± 3.19 μg/g dry extract), and oleanolic acid (551.831 ± 3.25 μg/g dry extract) were identified in high concentrations. A composition rich in the biologically active triterpenoid ursolic acid of the extract was highlighted, which was further investigated by isolation and characterization in the next step of our study.
According to other studies from the literature, fruits of C. metuliferus grown in an ecological farm on the Fruška gora Mountain (Pannonia plain, Novi Sad, Republic of Serbia) showed considerable amounts of polyphenols, expressed as gallic acid (GAE), in different parts of the plant, such as 58.22–74.90 mg GAE/100 g in pulp, between 1728.94 and 1923.52 mg GAE/100 g in peel extracts samples, and 141.25 mg GAE/100 g in seed extracts [23]. Another study that demonstrated the neuroprotective action of this plant presented the chemical composition of the fruits from Hby local farm located at Cinfães, Douro, Portugal, with smaller concentrations of gallic acid (11.7  ±  0.6 mg/100 g), p-coumaric acid (2.86 ± 0.14 mg/100 g), protocatechuic acid (7.69 ± 0.38 mg/100 g), (+)-catechin (4.86 ± 0.24 mg/100 g), and (-)-epicatechin (4.58 ± 0.23 mg/100 g) [63]. Several studies on the African species of C. metuliferus also highlighted the presence of a wide range of vitamins (vitamin A 198.51 mg/mL, B6 835.00 mg/mL, B12 0.10 mg/mL, C 682.00 mg/mL, D 5.28 mg/mL, E 0.42 mg/mL) [64,65] and minerals (Ca, Al, Mg, Zn, K) [22,64,66].

3.3. Analysis and Identification of Ursolic Acid

All the obtained fractions after the separation of the phytochemical compounds from the hydroethanolic extract of C. metuliferus fruits by using column chromatography were characterized through FT-IR, and the corresponding fraction of ursolic acid was identified. Ursolic acid was isolated from the ultrasound-assisted extract from kiwano fruit (Table 2) and further characterized by IR spectroscopy, mass spectroscopy, and 1H NMR, and the results were confirmed by comparing them with other studies [67,68,69].

3.3.1. FT-IR Analysis

All the fractions obtained after the separation of the phytochemical compounds from C. metuliferus fruit’s ethanolic extract using column chromatography were characterized through FT-IR analysis, and the functional groups were identified based on data in the literature. The fraction corresponding to ursolic acid was of interest, and in this study, the ATR-FTIR spectrum identified as ursolic acid was analyzed in a range of 4000 to 400 cm−1 with a resolution of 4 cm−1. Table 3 shows the vibration bands of ursolic acid and their characteristic functional groups. Interpretation and assignment of IR bands (Figure 2) were made based on data in the literature concerning ursolic acid [67,68,69,70].

3.3.2. Sample Analysis by UPLC-MS

The UHPLC-MS chromatographic data demonstrated that the isolated compound was the ursolic acid (supplementary material) by using the mass spectra.

3.3.3. NMR Analysis

The ursolic acid was identified using 1H-NMR spectroscopy by comparing the UA assignments with data in the literature. The 1H-NMR spectra of the isolated UA revealed the presence in the higher field region of five methyl groups by a corresponding singlet (0.77, 0.88, 0.95. 0.97, and 1.10 ppm), two methyl groups by a doublet (0.87 and 0.99 ppm), and the peaks were characteristic for the skeleton of ursane-type triterpenes [71,72]. Two singlet peaks at δH 1.10 ppm, characteristic for the methyl group of oleanane triterpene skeleton, and at δH 1.29 ppm for the methylene protons –CH2- were also observed in the isolated UA. The peak at δH 3.3 ppm from the lower field region, representing H, may be due to the hydroxyl group, and at δH 4.94 ppm, an olefinic proton peak was assigned to the H of a triterpene.
Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid): powder, white, 1H-NMR (CD3OD) (supplementary material); 1H-NMR (CD3OD): 1.63 & 1.69 (H-1,2H, m), 1.65 (H-2, 2H, m), 3.13 (H-3, 2H), 0.74 (H-5, 1H, d), 1.43 & 1.29 (H-6, 2H, m), 1.29 (H-7, 2H, m), 1.56 (H-9, 1H, m), 1.91 (H-11, 2H, q), 5.21 (H-12, 1H, t), 1.62 (H-15, 2H, m), 1.58 & 1.63 (H-16, 2H, m), 2.20 (H-18, 1H), 1.38 (H-19, 1H, m), 1.36 (H-20, 1H, m), 1.32 (H-21, 2H, m), 1.53(H-22, 2H, m), 0.95 (H-23, 3H, s), 0.77 (H-24, 3H, s), 0.97 (H-25, 3H, s), 0.84 (H-26, 3H, s), 1.10 (H-27, 3H, s), 0.87 (H-29, 3H, d), 0.95 (H-30, 3H, d).

3.4. Evaluation of the Antioxidant Activity

It is known that oxidative stress leads to the production of free radicals, and this can affect various cellular events, some of which are cancer proliferation, inflammation, and aging [73,74]. Various in vitro and in vivo studies have been performed to demonstrate the antioxidant of C. metuliferus extracts and ursolic acid, but only a few investigated the anti-inflammatory properties [65,75,76]. Table 4 shows the results of the two methods applied by us for the evaluation of the antioxidant activity data compared with Trolox and ascorbic acid, known for their antioxidant properties.
The purpose of this present research was to analyze the antioxidant activity of the hydroethanolic extract and also of the purified fraction of ursolic acid obtained from C. metuliferus. The obtained fraction of ursolic acid presented IC50 values (IC50 DPPH = 4.27 ± 0.009 µg/mL and IC50 ABTS = 6.96 ± 0.014 µg/mL) close to those reported by data in the literature for the pure compound [77,78,79], greater than that of ascorbic acid and Trolox. The extract demonstrated good antioxidant activity, greater than Trolox and ascorbic acid in an ABTS assay (IC50 = 11.37 ± 0.071 µg/mL). The antioxidant activity of C. metuliferus extract can be due to its rich composition in various active compounds, such as catechin, epicatechin, oleanolic acid, ursolic acid, and gallic acid.
Various studies on the extracts from C. metuliferus fruits cultivated in different geographic areas and also extracts from various parts of the plant showed different results [22]. Thus, other studies presented that the antioxidant activity of the extracts from the pulp by the DPPH method was 77.98 ± 2.13 µmol TE/100 g, by the ABTS method was 2508.69 ± 23.14 µmol TE/100 g, and that the peel extracts recorded higher activity for DPPH, 211.53 ± 7.95 µmol TE/100 g and 7845.91 ± 57.13 µmol TE/100 g for ABTS, respectively [22]. Seeds have weak antioxidant activity, as evaluated by the DPPH method (49.21 ± 1.15 µmol TE/100 g) and by the ABTS method (1425.196 ± 21.96 µmol TE/100 g) [22]. Another study showed that the DPPH and ABTS radical scavenging capacity of the methanolic extract from kiwano whole fruit was 20.88 µmol Trolox, equivalent per g, and, 185.36 µmol Trolox equivalent per g, respectively [23]. According to some studies, ursonic acid, which can be semi-synthesized by the oxidation of UA, has therapeutic potentials that are similar to or stronger than UA in some aspects. In particular, ursonic acid showed better anticancer, antiproliferative, and antiprotozoal effects [77]. Therefore, UA can be a good lead compound for the development of new derivatives with various therapeutic properties.

3.5. Evaluation of the in Vitro Anti-Inflammatory Activities

It is known that inflammation is liable for many diseases, such as diabetes, multiple sclerosis, arthritis, Parkinson’s, and Alzheimer’s among others, and is also associated with the progression of cancer cells [19,80].
Table 5 shows the results of this study, from which it appears that the proteinase inhibition activity of the C. metuliferus extract is mostly due to the presence of ursolic acid in its composition. The obtained results demonstrate that the isolated compound has a good anti-lipoxygenase activity, even if the values are lower compared to the known standards used, i.e., indomethacin and aspirin, so the C. metuliferus extract can be used as an alternative or as an adjuvant in suppressing inflammation.
Terpenoids are one of the classes of compounds present in plants that have demonstrated anti-inflammatory potential, ursolic acid being one of the representatives of this class [81]. The ability of ursolic acid to effectively inhibit aggregation of human platelet induced by arachidonic acid (IC50 = 0.26 mM) was also demonstrated through in vivo studies, compared to the activity of the known compounds quercetin (IC50 = 4.41 µM) and aspirin (28–71% inhibition at 150–300 mg/kg) [76]. Ursolic acid has been shown to exhibit weaker inhibitory activity (IC50 = 10 μM) than patuletin, but stronger activity than quercetin [75].

3.6. In Vitro Evaluation of the Antidiabetic Activity

The present research was designed to also evaluate the possible antidiabetic activity of C. metuliferus hydroethanolic extract by using in vitro enzyme assays. To investigate the pharmacological potential of hydroethanolic extract and isolated UA as amylase and glucosidase inhibitors in the development of new drugs to keep off and treat diabetes, they underwent specific tests. The results of the in vitro inhibition tests of α-amylase and α-glucosidase (Table 5) displayed that C. metuliferus extract had a similar inhibitory effect (IC50 α-amylase = 429.541 ± 0.252 µg/mL and IC50 βglucosidase = 385.685 ± 0.758 µg/mL) with that of the standard drug acarbose (IC50 α-amylase = 341.577 ± 0.398 µg/mL and IC50 βglucosidase = 308.474 ± 0.296 µg/mL). Several other studies demonstrated that triterpenoids and their derivatives could efficaciously inhibit the activity of glucosidase and amylase to diminish the absorption of carbohydrates [34,82]. These findings suggest that C. metuliferus extract could decrease the postprandial glucose level by inhibiting the activities of β-glucosidase or α-amylase, which are key enzymes in the digestion process of complex carbohydrates from food into adsorbable monosaccharides.

4. Conclusions

In this present work, the HPLC analysis was used to identify the chemical composition of the hydroethanolic extract of Cucumis metuliferus. The obtained results highlight the presence of 17 known phytochemical compounds in different amounts, including ursolic acid. A method of identification and isolation of ursolic acid, which presents antioxidant and anti-inflammatory activity, from the fruits of Cucumis metuliferus was proposed. The structure of the isolated compound was determined by IR spectroscopy, mass spectroscopy, and 1H NMR, and the data were confirmed by comparison with previously reported data. The obtained fraction showed antioxidant, anti-inflammatory, and antidiabetic activities, as well as the hydro-ethanolic extract. C. metuliferus exhibited considerable enzymatic inhibitory activity on key enzymes involved in diabetes and encourages the use of its extracts and phytochemical constituents, such as ursolic acid, in the prevention and therapy of diabetes mellitus. The results demonstrate the good activity of the hydro-ethanolic extracts obtained from fruits of Cucumis metuliferus “Tempus” grown in Romania due to the bioactive compounds identified in the extract, with major potential for various uses in disease management, as an alternative medicine to improve the overall health and wellness.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/separations10050274/s1, Figure S1: MS Spectra of fraction of C. metuliferus spicies with ursolic acid (negative 16 mode) performed on mass spectrometry; Figure S2: Proposed fragmentation pattern of ursolic acid, Figure S3. The 1H NMR spectrum of the ursolic acid fraction.

Author Contributions

Conceptualization, R.M.D. and A.C.B.; Data curation, A.V.D.B., A.C.B. and B.F.; Funding acquisition, R.M.D. and B.F.; Investigation A.C.B., G.V.C. and A.V.D.B.; Methodology, R.M.D., A.V.D.B., A.C.B. and B.F.; Project administration R.M.D. and A.C.B.; Resources R.M.D. and B.F. Software A.V.D.B.; Supervision, R.M.D. and B.F.; Visualization A.C.B., A.V.D.B. and G.V.C.; Writing—original draft, A.C.B., A.V.D.B. and R.M.D.; Writing—review and editing, R.M.D., A.V.D.B., A.C.B. and B.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

The data presented in this study are available in the figures and supplementary materials.

Acknowledgments

The authors are grateful for the technical support provided by the MoRAS and ECEE Centers, and by “Dunarea de Jos” University, to Costel Vînătoru (Plant Genetic Resources Bank for Vegetables, Floriculture, Aromatic, and Medicinal Plants Buzău, 56 Nicolae Bălcescu Street, 120187, Buzau, Romania), and the Research-Development Station for Vegetable Growing Buzău for the plant material that was used in this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Fischer, N.M.; Pallazola, V.A.; Xun, H.; Cainzos-Achirica, M.; Michos, E.D. The evolution of the heart-healthy Ddet for vascular health: A walk through Time. Vasc. Med. 2020, 25, 184–193. [Google Scholar] [CrossRef] [PubMed]
  2. Dzah, C.S.; Asante-Donyinah, D.; Letsyo, E.; Dzikunoo, J.; Adams, Z.S. Dietary olyphenols and obesity: A Review of polyphenol effects on lipid and glucose metabolism, mitochondrial homeostasis, and starch digestibility and absorption. Plant Foods Hum. Nutr. 2023, 78, 1–12. [Google Scholar] [CrossRef] [PubMed]
  3. Lutz, M. Healthy sustainable food patterns and systems: A planetary urgency. Medwave 2021, 21, e8436. [Google Scholar] [CrossRef] [PubMed]
  4. Dinu, M.; Pagliai, G.; Sofi, F. A heart-healthy diet: Recent insights and practical recommendations. Curr. Cardiol. Rep. 2017, 19, 95. [Google Scholar] [CrossRef]
  5. Van Raaij, J.; Hendriksen, M.; Verhagen, H. Potential for improvement of population diet through reformulation of commonly eaten foods. Public Health Nutr. 2009, 12, 325–330. [Google Scholar] [CrossRef]
  6. Herforth, A.; Arimond, M.; Álvarez-Sánchez, C.; Coates, J.; Christianson, K.; Muehlhoff, E. A global review of food-based dietary guidelines. Adv. Nutr. 2019, 10, 590–605. [Google Scholar] [CrossRef]
  7. Ekstrand, B.; Scheers, N.; Rasmussen, M.K.; Young, J.F.; Ross, A.B.; Landberg, R. Brain Foods—The role of diet in brain performance and health. Nutr. Rev. 2021, 79, 693–708. [Google Scholar] [CrossRef]
  8. Mozaffarian, D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity. Circulation 2016, 133, 187–225. [Google Scholar] [CrossRef]
  9. Pistollato, F.; Iglesias, R.C.; Ruiz, R.; Aparicio, S.; Crespo, J.; Lopez, L.D.; Manna, P.P.; Giampieri, F.; Battino, M. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies. Pharmacol. Res. 2018, 131, 32–43. [Google Scholar] [CrossRef]
  10. Opie, R.S.; Itsiopoulos, C.; Parletta, N.; Sanchez-Villegas, A.; Akbaraly, T.N.; Ruusunen, A.; Jacka, F.N. Dietary Recommendations for the prevention of depression. Nutr. Neurosci. 2017, 20, 161–171. [Google Scholar] [CrossRef]
  11. Wang, X. Healthy diet during pregnancy—Navigating the double-ddged Sword. Am. J. Clin. Nutr. 2021, 114, 414–415. [Google Scholar] [CrossRef] [PubMed]
  12. Omokhua-Uyi, A.G.; Van Staden, J. Phytomedicinal relevance of South African Cucurbitaceae species and their safety assessment: A review. J. Ethnopharmacol. 2020, 259, 112967. [Google Scholar] [CrossRef] [PubMed]
  13. Busuioc, A.C.; Botezatu, A.V.D.; Furdui, B.; Vinatoru, C.; Maggi, F.; Caprioli, G.; Dinica, R.M. Comparative study of the chemical compositions and antioxidant activities of fresh juices from Romanian Cucurbitaceae varieties. Molecules 2020, 25, 5468. [Google Scholar] [CrossRef] [PubMed]
  14. Murthy, H.N.; Paek, K.-Y. Bioactive Compounds in Underutilized Vegetables and Legumes; Murthy, H.N., Paek, K.Y., Eds.; Reference Series in Phytochemistry; Springer International Publishing: Cham, Switzerland, 2021; ISBN 978-3-030-57414-7. [Google Scholar]
  15. Usman, J.G.; Sodipo, O.A.; Kwaghe, A.V.; Sandabe, U.K. Uses of Cucumis metuliferus: A review. Cancer Biol. 2015, 5, 24–34. [Google Scholar]
  16. Bisognin, D.A. Origin and evolution of cultivated Cucurbits. Ciência Rural 2002, 32, 715–723. [Google Scholar] [CrossRef]
  17. Hartman, J.L.; Wehner, T.C.; Ma, G.; Perkins-Veazie, P. Citrulline and arginine content of taxa of Cucurbitaceae. Horticulturae 2019, 5, 22. [Google Scholar] [CrossRef]
  18. Mallick, M.F.R.; Masui, M. Origin, Distribution and taxonomy of melons. Sci. Hortic. 1986, 28, 251–261. [Google Scholar] [CrossRef]
  19. González, R.; Ballester, I.; López-Posadas, R.; Suárez, M.D.; Zarzuelo, A.; Martínez-Augustin, O.; Sánchez de Medina, F. Effects of flavonoids and other polyphenols on inflammation. Crit. Rev. Food Sci. Nutr. 2011, 51, 331–362. [Google Scholar] [CrossRef]
  20. Innih, S.O.; Eze, I.G.; Omage, K. Cardiovascular benefits of Momordica charantia in cholesterol-fed wistar rats. Clin. Phytosci. 2021, 7, 65. [Google Scholar] [CrossRef]
  21. De Melo, M.L.S.; Narain, N.; Bora, P.S. Characterisation of some nutritional constituents of melon (Cucumis melo hybrid AF-522) seeds. Food Chem. 2000, 68, 411–414. [Google Scholar] [CrossRef]
  22. Šovljanski, O.; Šeregelj, V.; Pezo, L.; Šaponjac, V.T.; Vulić, J.; Cvanić, T.; Markov, S.; Ćetković, G.; Čanadanović-Brunet, J. Horned melon pulp, peel, and seed: New insight into phytochemical and biological properties. Antioxidants 2022, 11, 825. [Google Scholar] [CrossRef] [PubMed]
  23. Šeregelj, V.; Šovljanski, O.; Šaponjac, V.T.; Vulić, J.; Ćetković, G.; Markov, S.; Čanadanović-Brunet, J. Horned melon (Cucumis metuliferus E. Meyer Ex. Naudin)—Current knowledge on its phytochemicals, biological benefits, and potential applications. Processes 2022, 10, 94. [Google Scholar] [CrossRef]
  24. Ferrara, L. The dietary importance of a tropical fruit: The kiwano. Ingred. Aliment. 2006, 5, 14–17. [Google Scholar]
  25. Anyanwu, A.; Jimam, N.; Wannang, N. Assessment of the effects of Cucumis metuliferus fruits alkaloids against Newcastle disease virus-LaSota. Environ. Dis. 2016, 1, 130. [Google Scholar] [CrossRef]
  26. Seo, D.Y.; Lee, S.R.; Heo, J.W.; No, M.H.; Rhee, B.D.; Ko, K.S.; Kwak, H.B.; Han, J. Ursolic acid in health and disease. Korean J. Physiol. Pharmacol. 2018, 22, 235–248. [Google Scholar] [CrossRef]
  27. Ramos-Hryb, A.B.; Pazini, F.L.; Kaster, M.P.; Rodrigues, A.L.S. Therapeutic potential of ursolic acid to manage neurodegenerative and psychiatric diseases. CNS Drugs 2017, 31, 1029–1041. [Google Scholar] [CrossRef] [PubMed]
  28. Iqbal, J.; Abbasi, B.A.; Ahmad, R.; Mahmood, T.; Kanwal, S.; Ali, B.; Khalil, A.T.; Shah, S.A.; Alam, M.M.; Badshah, H. Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications. Biomed. Pharmacother. 2018, 108, 752–756. [Google Scholar] [CrossRef]
  29. Venugopal, R.; Liu, R.H. Phytochemicals in diets for breast cancer prevention: The importance of resveratrol and ursolic acid. Food Sci. Hum. Wellness 2012, 1, 1–13. [Google Scholar] [CrossRef]
  30. Ramirez, C.N.; Li, W.; Zhang, C.; Wu, R.; Su, S.; Wang, C.; Gao, L.; Yin, R.; Kong, A.N.T. In vitro-in vivo dose response of ursolic acid, sulforaphane, PEITC, and curcumin in cancer prevention. AAPS J. 2018, 20, 19. [Google Scholar] [CrossRef]
  31. Gu, W.; Hao, Y.; Zhang, G.; Wang, S.F.; Miao, T.T.; Zhang, K.P. Synthesis, in vitro antimicrobial and cytotoxic activities of new carbazole derivatives of ursolic acid. Bioorg. Med. Chem. Lett. 2015, 25, 554–557. [Google Scholar] [CrossRef]
  32. Shao, J.W.; Dai, Y.C.; Xue, J.P.; Wang, J.C.; Lin, F.P.; Guo, Y.H. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives. Eur. J. Med. Chem. 2011, 46, 2652–2661. [Google Scholar] [CrossRef]
  33. Mlala, S.; Oyedeji, A.O.; Gondwe, M.; Oyedeji, O.O. Ursolic acid and its derivatives as bioactive agents. Molecules 2019, 24, 2751. [Google Scholar] [CrossRef]
  34. Wu, P.P.; Zhang, K.; Lu, Y.J.; He, P.; Zhao, S.Q. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives. Eur. J. Med. Chem. 2014, 80, 502–508. [Google Scholar] [CrossRef] [PubMed]
  35. Yang, P.; Li, Y.; Liu, X.; Jiang, S. Determination of free isomeric oleanolic acid and ursolic acid in Pterocephalus hookeri by capillary zone electrophoresis. J. Pharm. Biomed. Anal. 2007, 43, 1331–1334. [Google Scholar] [CrossRef] [PubMed]
  36. Wang, J.; Liu, L.; Qiu, H.; Zhang, X.; Guo, W.; Chen, W.; Tian, Y.; Fu, L.; Shi, D.; Cheng, J.; et al. Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. PLoS ONE 2013, 8, e63872. [Google Scholar] [CrossRef] [PubMed]
  37. Xu, X.H.; Su, Q.; Zang, Z.H. Simultaneous determination of oleanolic acid and ursolic acid by RP-HPLC in the leaves of Eriobotrya japonica Lindl. J. Pharm. Anal. 2012, 2, 238–240. [Google Scholar] [CrossRef]
  38. Shanmuga Sundaram, R.; Ramanathan, M.; Rajesh, R.; Satheesh, B.; Saravanan, D. LC-MS quantification of rosmarinic acid and ursolic acid in the Ocimum sanctum Linn. leaf extract (Holy Basil, Tulsi). J. Liq. Chromatogr. Relat. Technol. 2012, 35, 634–650. [Google Scholar] [CrossRef]
  39. Fan, J.P.; Kong, T.; Zhang, L.; Tong, S.; Tian, Z.Y.; Duan, Y.H.; Zhang, X.H. Solubilities of ursolic acid and oleanolic acid in four solvents from (283.2 to 329.7) K. J. Chem. Eng. Data 2011, 56, 2723–2725. [Google Scholar] [CrossRef]
  40. Fan, J.P.; Liao, D.D.; Zhang, X.H. Ultrasonic assisted extraction of ursolic acid from apple pomace: A novel and facile technique. Sep. Sci. Technol. 2016, 51, 1344–1350. [Google Scholar] [CrossRef]
  41. Wang, X.; Sun, W.; Cao, J.; Qu, H.; Bi, X.; Zhao, Y. Structures of new triterpenoids and cytotoxicity activities of the isolated major compounds from the fruit of Momordica charantia L. J. Agric. Food Chem. 2012, 60, 3927–3933. [Google Scholar] [CrossRef]
  42. Tian, S.; Shi, Y.; Yu, Q.; Upur, H. Determination of oleanolic acid and ursolic acid contents in Ziziphora clinopodioides Lam. by HPLC method. Pharmacogn. Mag. 2010, 6, 116–119. [Google Scholar] [CrossRef]
  43. Wandjou, J.G.N.; Mevi, S.; Sagratini, G.; Vittori, S.; Dall’acqua, S.; Caprioli, G.; Lupidi, G.; Mombelli, G.; Arpini, S.; Allegrini, P.; et al. Antioxidant and enzyme inhibitory properties of the polyphenolic-rich extract from an ancient apple variety of central Italy (Mela rosa dei Monti Sibillini). Plants 2020, 9, 9. [Google Scholar] [CrossRef]
  44. Verma, S.C.; Jain, C.L.; Kumari, A.; Padhi, M.M.; Devalla, R.B. Microwave-assisted extraction and rapid isolation of ursolic acid from the leaves of eucalyptus × Hybrida maiden and its quantification using HPLC-diode array Technique. J. Sep. Sci. 2013, 36, 1255–1262. [Google Scholar] [CrossRef]
  45. Kaur, P.; Gupta, R.C.; Dey, A.; Kumar Pandey, D. Simultaneous quantification of oleanolic acid, ursolic acid, betulinic acid and lupeol in different populations of five Swertia species by using HPTLC-densitometry: Comparison of different extraction methods and solvent selection. Ind. Crops Prod. 2019, 130, 537–546. [Google Scholar] [CrossRef]
  46. Zongo, E.; Busuioc, A.; Meda, R.N.-T.; Botezatu, A.V.; Mihaila, M.D.; Mocanu, A.-M.; Avramescu, S.M.; Koama, B.K.; Kam, S.E.; Belem, H.; et al. Exploration of the antioxidant and anti-inflammatory potential of Cassia sieberiana DC and Piliostigma thonningii (Schumach.) Milne-Redh, traditionally used in the treatment of hepatitis in the Hauts-Bassins region of Burkina Faso. Pharmaceuticals 2023, 16, 133. [Google Scholar] [CrossRef] [PubMed]
  47. Costea, L.; Chițescu, C.L.; Boscencu, R.; Ghica, M.; Lupuliasa, D.; Mihai, D.P.; Deculescu-ioniță, T.; Duțu, L.E.; Popescu, M.L.; Luță, E.A.; et al. The polyphenolic profile and antioxidant activity of five vegetal extracts with hepatoprotective potential. Plants 2022, 11, 1680. [Google Scholar] [CrossRef]
  48. Fouedjou, R.T.; Nguelefack, E.P.; Ponou, B.K.; Nguelefack, T.B.; Barboni, L.; Tapondjou, L.A. Antioxidant activities and chemical constituents of extracts from Cordyline fruticosa (L.) A. Chev. (Agavaceae) and Eriobotrya japonica (Thunb) Lindl, (Rosaceae). Pharmacologia 2016, 7, 103–113. [Google Scholar] [CrossRef]
  49. Kaur, N.; Chahal, K.; Singh, R.U. Phytochemical screening and antioxidant activity of Anethum graveolens L. seed extracts. Pharma Innov. J. 2018, 7, 324–329. [Google Scholar]
  50. Matsusaka, Y.; Kawabata, J. Evaluation of antioxidant capacity of non-edible parts of some selected tropical fruits. Food Sci. Technol. Res. 2010, 16, 467–472. [Google Scholar] [CrossRef]
  51. Sirivibulkovit, K.; Nouanthavong, S.; Sameenoi, Y. Paper-Based DPPH assay for antioxidant activity analysis. Anal. Sci. 2018, 34, 795–800. [Google Scholar] [CrossRef]
  52. Dinica, R.M.; Sandu, C.; Botezatu, A.V.D.; Busuioc, A.C.; Balanescu, F.; Mihaila, M.D.I.; Dumitru, C.N.; Furdui, B.; Iancu, A.V. Allantoin from valuable Romanian animal and plant sources with promising anti-inflammatory activity as a nutricosmetic ingredient. Sustainability 2021, 13, 170. [Google Scholar] [CrossRef]
  53. Saravanakumar, K.; Park, S.J.; Mariadoss, A.V.A.; Sathiyaseelan, A.; Veeraraghavan, V.P.; Kim, S.J.; Wang, M.H. Chemical composition, cntioxidant, and anti-diabetic activities of ethyl acetate fraction of Stachys riederi Var. Japonica (Miq.) in streptozotocin-induced Type 2 diabetic mice. Food Chem. Toxicol. 2021, 155, 112374. [Google Scholar] [CrossRef]
  54. Wojdyło, A.; Oszmiański, J.; Czemerys, R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007, 105, 940–949. [Google Scholar] [CrossRef]
  55. Bălănescu, F.; Botezatu, A.V.; Marques, F.; Busuioc, A.; Marincaş, O.; Vînătoru, C.; Cârâc, G.; Furdui, B.; Dinica, R.M. Bridging the chemical profile and biological activities of a new variety of Agastache foeniculum (Pursh) Kuntze extracts and essential oil. Int. J. Mol. Sci. 2023, 24, 828. [Google Scholar] [CrossRef]
  56. Okpoko, C.; Ezenyi, I.; Adzu, B.; Salawu, O. Evaluation of two medicinal plants used for arthritis in Northern Nigeria with focus on Terminalia avicennioides Guill. & Perr. and its mechanism of action. Sci. African 2020, 8, e00357. [Google Scholar] [CrossRef]
  57. Fofana, S.; Gnoula, C.; Draogo, M.O.E.; Eacute, E.P.; Eacute, R.H.N.E.B.; Nikiema, J.B.; Guissou, I.P.; Simpore, J. DPPH radical scavenging and lipoxygenase inhibitory effects in extracts from Erythrina senegalensis (Fabaceae) DC. Afr. J. Pharm. Pharmacol. 2016, 10, 185–191. [Google Scholar] [CrossRef]
  58. Naz, R.; Ayub, H.; Nawaz, S.; Islam, Z.U.; Yasmin, T.; Bano, A.; Wakeel, A.; Zia, S.; Roberts, T.H. Antimicrobial activity, toxicity and anti-inflammatory potential of methanolic extracts of four ethnomedicinal plant species from Punjab, Pakistan. BMC Complement. Altern. Med. 2017, 17, 302. [Google Scholar] [CrossRef]
  59. Oyedepo, O.O.; Femurewa, A.J. Anti-protease and membrane stabilizing activities of extracts of Fagra zanthoxiloides, Olax subscorpioides and Tetrapleura tetraptera. Int. J. Pharm. 1995, 33, 65–69. [Google Scholar] [CrossRef]
  60. Wan, L.S.; Chen, C.P.; Xiao, Z.Q.; Wang, Y.L.; Min, Q.X.; Yue, Y.D.; Chen, J.C. In vitro and in vivo anti-diabetic activity of Swertia kouitchensis extract. J. Ethnopharmacol. 2013, 147, 622–630. [Google Scholar] [CrossRef]
  61. Sales, P.M.; Souza, P.M.; Simeoni, L.A.; Magalhães, P.O.; Silveira, D. α-Amylase inhibitors: A Review of raw material and isolated compounds from plant source. J. Pharm. Pharm. Sci. 2012, 15, 141. [Google Scholar] [CrossRef]
  62. Ngenge Tamfu, A.; Mfifen Munvera, A.; Veronica Dediu Botezatu, A.; Talla, E.; Ceylan, O.; Tagatsing Fotsing, M.; Tanyi Mbafor, J.; Shaheen, F.; Mihaela Dinica, R. Synthesis of benzoyl esters of β-amyrin and lupeol and evaluation of their antibiofilm and antidiabetic activities. Results Chem. 2022, 4, 100322. [Google Scholar] [CrossRef]
  63. Vieira, E.F.; Podlasiak, M.; Moreira, M.M.; Grosso, C.; Rodrigues, F.; Fernandes, V.C.; Delerue-Matos, C. New insights of phytochemical profile and in vitro antioxidant and neuroprotective activities from optimized extract of horned melon fruit. J. Food Meas. Charact. 2022, 16, 1847–1858. [Google Scholar] [CrossRef]
  64. Maluleke, M.K.; Moja, S.J.; Nyathi, M.; Modise, D.M. Nutrient concentration of African horned cucumber (Cucumis metuliferus L.) fruit under different soil types, environments, and varying irrigation water levels. Horticulturae 2021, 7, 76. [Google Scholar] [CrossRef]
  65. Bogopa, J. P2 Exploring the functional components of the African horned cucumber (Cucumis metuliferus), Mokapana (Tswana)—Characterisation by phenolic content and antioxidant activity in Botswana. Biochem. Pharmacol. 2017, 139, 125. [Google Scholar] [CrossRef]
  66. Ani, O.N.; Achikanu, C.E.; Onyishi, C.K. Comparative analysis of minerals, heavy metals and amino acids compositions of the seeds and juice of Cucumis metuliferus. Asian J. Res. Biochem. 2020, 54, 31–42. [Google Scholar] [CrossRef]
  67. Pai, S.R.; Upadhya, V.; Hegde, H.V.; Joshi, R.K.; Kholkute, S.D. Determination of betulinic acid, oleanolic acid and ursolic acid from Achyranthes aspera L. using RP-UFLC-DAD analysis and evaluation of various parameters for their optimum Yield. Indian J. Exp. Biol. 2016, 54, 196–202. [Google Scholar]
  68. Zhou, Z.; Tong, H.H.Y.; Li, L.; Shek, F.L.Y.; Lv, Y.; Zheng, Y. Synthesis, characterization and thermal analysis of ursolic acid solid forms. Cryst. Res. Technol. 2015, 50, 538–548. [Google Scholar] [CrossRef]
  69. Gómez-Pulido, L.D.M.; González-Cano, R.C.; Domínguez, E.; Heredia, A. Structure determination of oleanolic and ursolic acids: A combined density functional theory/vibrational spectroscopy methodology. R. Soc. Open Sci. 2021, 8, 210162. [Google Scholar] [CrossRef]
  70. Samsonowicz, M.; Kalinowska, M.; Gryko, K. Enhanced Antioxidant activity of ursolic acid by complexation with copper (II): Experimental and theoretical study. Materials 2021, 14, 264. [Google Scholar] [CrossRef]
  71. Sang, S.; Lapsley, K.; Rosen, R.T.; Ho, C.T. New prenylated benzoic acid and other constituents from almond hulls (Prunus amygdalus Batsch). J. Agric. Food Chem. 2002, 50, 607–609. [Google Scholar] [CrossRef]
  72. Somantri, A.D.; Kurnia, D.; Zainuddin, A.; Dharsono, H.D.; Satari, M.H. Action mode of ursolic acid as a natural antioxidant and inhibitor of superoxide dismutase: In vitro and in silico study. J. Adv. Pharm. Technol. Res. 2021, 12, 389–394. [Google Scholar] [CrossRef]
  73. Krishnaiah, D.; Sarbatly, R.; Nithyanandam, R. A Review of the antioxidant potential of medicinal plant species. Food Bioprod. Process. 2011, 89, 217–233. [Google Scholar] [CrossRef]
  74. Alam, M.N.; Bristi, N.J.; Rafiquzzaman, M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm. J. 2013, 21, 143–152. [Google Scholar] [CrossRef]
  75. Jedinák, A.; Mučková, M.; Košt’álová, D.; Maliar, T.; Mašterová, I. Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis. Z. Fur Nat.-Sect. C J. Biosci. 2006, 61, 777–782. [Google Scholar] [CrossRef]
  76. Checker, R.; Sandur, S.K.; Sharma, D.; Patwardhan, R.S.; Jayakumar, S.; Kohli, V.; Sethi, G.; Aggarwal, B.B.; Sainis, K.B. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-ΚB, AP-1 and NF-AT. PLoS ONE 2012, 7, e31318. [Google Scholar] [CrossRef]
  77. Son, J.; Lee, S.Y. Therapeutic potential of ursonic acid: Comparison with ursolic acid. Biomolecules 2020, 10, 1505. [Google Scholar] [CrossRef]
  78. Jabeen, M.; Ahmad, S.; Shahid, K.; Sadiq, A.; Rashid, U. Ursolic acid hydrazide based organometallic complexes: Synthesis, characterization, antibacterial, antioxidant, and docking studies. Front. Chem. 2018, 6, 55. [Google Scholar] [CrossRef] [PubMed]
  79. Ramachandran, S.; Prasad, N.R. Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes. Chem. Biol. Interact. 2008, 176, 99–107. [Google Scholar] [CrossRef]
  80. Pradhan, B.; Patra, S.; Behera, C.; Nayak, R.; Jit, B.P.; Ragusa, A.; Jena, M. Preliminary investigation of the antioxidant, anti-diabetic, and anti-inflammatory activity of Enteromorpha intestinalis extracts. Molecules 2021, 26, 1171. [Google Scholar] [CrossRef] [PubMed]
  81. Woźniak, Ł.; Skąpska, S.; Marszałek, K. Ursolic acid—A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 2015, 20, 20614–20641. [Google Scholar] [CrossRef] [PubMed]
  82. Ali, H.; Houghton, P.J.; Soumyanath, A. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J. Ethnopharmacol. 2006, 107, 449–455. [Google Scholar] [CrossRef] [PubMed]
Separations 10 00274 g001 550
Figure 1. Separation scheme starting from the fruits of C. metuliferus.
Figure 1. Separation scheme starting from the fruits of C. metuliferus.
Separations 10 00274 g001
Separations 10 00274 g002 550
Figure 2. The FTIR-ATR spectra of pure ursolic acid (purple spectra) and isolated ursolic acid (UA, red spectra).
Figure 2. The FTIR-ATR spectra of pure ursolic acid (purple spectra) and isolated ursolic acid (UA, red spectra).
Separations 10 00274 g002
Table
Table 1. Chemical composition of the hydroethanolic extract of the fruit of C. metuliferus from HPLC-DAD analysis.
Table 1. Chemical composition of the hydroethanolic extract of the fruit of C. metuliferus from HPLC-DAD analysis.
CompoundHPLC-DADUHPLC-MS
RT *λ,
nm		μg/g of ExtractSD **RSD %Exact Mass[M-H]− Ion (m/z)
Hydroxybenzoic acids
Gallic acid5.9272.00401.391.460.36170.02152169.01302
Catechin17.6280.006576.763.860.06290.07904289.071
Epicatechin23.9280.002016.713.590.18302.04265289.071
Procianidin B224.3230.0035.880.220.61578.14242577.1558
Procianidin A229.9230.00756.101.860.25578.14242577.1558
Flavonols
Rutin31.4265.0039.420.230.60610.15338609.14613
Quercetin35.8365.005.980.569.43302.04265301.23813
Quercetin-3-D-galactoside32.0265.0011.620.282.45464.09548463.0876
Kampferol-3-glucoside33.6265.0021.900.703.20448.10056447.09331
Kampferol37.8365.005.141.4928.88286.04774285.13422
Hydrocinnamic acids
Neochlorogenic acid10.5325.0022.890.532.31
Chlorogenic acid22.3325.0077.390.150.19354.09508354.09508
Caffeic acid22.9325.0058.650.570.96180.04226179.03501
p-Coumaric acid28.9325.00116.111.461.26164.04734163.03954
trans-Ferulic acid30.5325.0034.271.865.42194.05791193.05066
Triterpenes
Oleanolic acid45.8210.00551.833.250.59456.36034455.35309
Ursolic acid45.9210.00577.313.190.55456.36034455.35309
* RT—retention time; ** SD—standard deviation.
Table
Table 2. Characterization of the isolated compound.
Table 2. Characterization of the isolated compound.
Physical PropertiesUrsolic Acid Fraction
Color white
Melting Point 291–293 °C
Solubility soluble in ethanol, DMSO
Rf Value
Solvent system: chloroform: methanol (95:5, v/v)		0.41
Table
Table 3. The main characteristic experimental FTIR-ATR bands (cm−1) of standard commercial UA and isolated UA from C. metuliferus fruits extract and their assignments.
Table 3. The main characteristic experimental FTIR-ATR bands (cm−1) of standard commercial UA and isolated UA from C. metuliferus fruits extract and their assignments.
AssignmentsATR-IR Bands (cm−1)
Standard Commercial UAIsolated UA from C. metuliferus
νass (OH) w3523.333523.22
ν (O–H) w2965.412966.61
ν (CH) m2953.90; 2918.752954.34; 2918.32
νass (C=O) s1714.661715.54
νas (COO−) w1553.561543.80
βas (OH) m1453.781454.54
νs (COO−; C=O) w1405.151406.03
δs (CH3) w1385.721386.45
βs (OH) m1374.721375.79
ν(C–OH) m1029.871030.96
γ (−C=C−, CH) m999.56999.59
ν (C–C, C–O, C–H) w971.08972.12
δs (CH3) w807.15808.14
and intensities: s—strong, w—weak, m—medium; νass—asymmetric stretch; νs—symmetric stretch.
Table
Table 4. Evaluation of the antioxidant activity.
Table 4. Evaluation of the antioxidant activity.
SamplesIC50 DPPH (µg/mL)IC50 ABTS (µg/mL)
Fruit extract32.74 ± 0.022 d11.37 ± 0.071 b
Isolated ursolic acid4.27 ± 0.009 a6.96 ± 0.014 a
Trolox10.57 ± 0.002 b32.56 ± 0.002 c
Ascorbic acid20.34 ± 0.034 c13.76 ± 0.044 b
The values succeeded by the same letters (a, b, c, d) in the same column show no statistically significant differences (p < 0.05) according to the analysis of variance (ANOVA).
Table
Table 5. Evaluation of the anti-inflammatory and antidiabetic activities.
Table 5. Evaluation of the anti-inflammatory and antidiabetic activities.
SamplesAnti-Lipoxygenase Activity
IC50 (µg/mL) *		Anti-Proteinase Action
IC50 (µg/mL) *		α-amylase Inhibition IC50 (µg/mL) *β-glucosidase Inhibition IC50 (µg/mL) *
Hydroethanolic extract32.90 ± 0.045 b16.34 ± 0.067 b429.541 ± 0.252 c385.685 ± 0.758 c
Ursolic acid fraction18.61 ± 0.086 a12.53 ± 0.044 a394.264 ± 0.143 b322.412 ± 0.517 b
Aspirin 160.20 ± 0.020c
Indomethacin45.12 ± 0.014 c
Acarbose 341.577 ± 0.398 a308.474 ± 0.296 a
* The values succeeded by the same letters (a, b, c) in the same column show no statistically signifcant differences (p < 0.05) according to the analysis of variance (ANOVA).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Busuioc, A.C.; Costea, G.V.; Botezatu, A.V.D.; Furdui, B.; Dinica, R.M. Cucumis metuliferus L. Fruits Extract with Antioxidant, Anti-Inflammatory, and Antidiabetic Properties as Source of Ursolic Acid. Separations 2023, 10, 274. https://doi.org/10.3390/separations10050274

AMA Style

Busuioc AC, Costea GV, Botezatu AVD, Furdui B, Dinica RM. Cucumis metuliferus L. Fruits Extract with Antioxidant, Anti-Inflammatory, and Antidiabetic Properties as Source of Ursolic Acid. Separations. 2023; 10(5):274. https://doi.org/10.3390/separations10050274

Chicago/Turabian Style

Busuioc, Anna Cazanevscaia, Giorgiana Valentina Costea, Andreea Veronica Dediu Botezatu, Bianca Furdui, and Rodica Mihaela Dinica. 2023. "Cucumis metuliferus L. Fruits Extract with Antioxidant, Anti-Inflammatory, and Antidiabetic Properties as Source of Ursolic Acid" Separations 10, no. 5: 274. https://doi.org/10.3390/separations10050274

APA Style

Busuioc, A. C., Costea, G. V., Botezatu, A. V. D., Furdui, B., & Dinica, R. M. (2023). Cucumis metuliferus L. Fruits Extract with Antioxidant, Anti-Inflammatory, and Antidiabetic Properties as Source of Ursolic Acid. Separations, 10(5), 274. https://doi.org/10.3390/separations10050274

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop